Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antibodies), by Transplant, by Distribution Channel, and Segment Forecasts, 2019 - 2026

Published: Oct, 2019 | Pages: 110 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global organ transplant immunosuppressant drugs market size is expected to reach USD 5.88 billion by 2026, according to a new report by Grand View Research. Growing patient population requiring organ transplantations and increasing approval of novel products are the factors driving the market growth. However, the high procedural cost of transplantations, the disproportion in the supply and demand for organs, and uncertain reimbursement scenario are the major factors restraining the market growth.

According to the Health Resources & Services Administration and the U.S. Department of Health and Human Services, more than 113,000 people were in need of transplants as of January 2019 and 36,528 transplants were performed in 2018. Hence, there is huge demand for organ transplants that will further boost the market. Kidney transplant held the largest market share in the transplant segment and is expected to retain its leading position through the forecast period. This can be attributed to increasing demand and comparatively better availability of kidneys than other organs.

Among the drug classes, the calcineurin inhibitors are expected to dominate the global organ transplant immunosuppressant drugs market through the forecast period. There are two drugs in this drug class, Prograf (tacrolimus) and Neoral/Sandimmune (cyclosporine). Although these effective immunosuppressants have been used in kidney transplant recipients for more than 20 years, they hold extensive toxicity profiles. Asia Pacific is expected to show the highest CAGR, while North America is expected to hold the largest share during the forecast period.

Further key findings from the study suggest:

• Calcineurin inhibitors are expected to command the largest market share in the drug class segment. Calcineurin inhibitors inhibit the activation action of T-cells of the immune system by the enzyme calcineurin.

• Calcineurin inhibitors such as tacrolimus and cyclosporine are the cornerstone of immunosuppression for kidney transplantation. In more than 85% cases of kidney transplant, tacrolimus is prescribed as a part of the patients' maintenance immunosuppressive regimen.

• Kidney transplant is expected to maintain its dominance through the forecast period due to the increasing demand for kidney replacement procedures

• Asia Pacific regional market is expected to demonstrate the fastest growth over the forecast period due to rising per capita healthcare expenditure, improving healthcare infrastructure, and increasing demand for organ transplantations in the region

• Key players operating in this space include Astellas Pharma, Inc., Sanofi Genzyme, Accord Healthcare Ltd., Novartis AG, Mylan Laboratories, Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Veloxis Pharmaceuticals A/S, and Bristol-Myers Squibb Company.

 Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Market segmentation & scope
                 1.2 Market definition
                 1.3 Information procurement
                     1.3.1 Purchased database
                     1.3.2 GVR's internal database
                     1.3.3 Secondary sources & third party perspectives
                     1.3.4 Primary research
                 1.4 Information analysis
                     1.4.1 Data analysis models
                 1.5 Market formulation & data visualization
                 1.6 Data validation & publishing
Chapter 2 Executive Summary
                 2.1 Market Outlook
                 2.2 Segment Outlook
                 2.3 Competitive Insights
Chapter 3 Organ Transplant Immunosuppressant Drugs Market Variables, Trends & Scope
                 3.1 Market Lineage Outlook
                     3.1.1 Parent Market Outlook
                     3.1.2 Ancillary Market Outlook
                 3.2 Penetration and Growth Prospect Mapping
                 3.3 Regulatory Framework
                 3.4 Market Dynamics
                     3.4.1 Market driver analysis
                     3.4.2 Market Restraint Analysis
                     3.4.3 Industry challenges
                 3.5 Organ Transplant Immunosuppressant Drugs Market Analysis Tools
                     3.5.1 Industry analysis - Porter's
                         3.5.1.1 Supplier Power
                         3.5.1.2 Buyer Power
                         3.5.1.3 Substitution Threat
                         3.5.1.4 Threat from new entrants
                         3.5.1.5 Competitive Rivalry
                     3.5.2 PESTEL Analysis
                         3.5.2.1 Political landscape
                         3.5.2.2 Environmental landscape
                         3.5.2.3 Social landscape
                         3.5.2.4 Technology landscape
                         3.5.2.5 Legal landscape
                     3.5.3 Major deals and strategic alliances analysis
                         3.5.3.1 Joint ventures
                         3.5.3.2 Mergers and acquisitions
                         3.5.3.3 Licensing and partnership
                         3.5.3.4 Technology collaborations
                         3.5.3.5 Strategic Divestments
                     3.5.4 Market entry strategies
Chapter 4 Organ Transplant Immunosuppressant Drugs Market - Competitive Analysis
                 4.1 Recent Developments & Impact Analysis, by Key Market Participants
                 4.2 Company Categorization
                 4.3 Vendor Landscape
                     4.3.1 List of key distributors and channel partners
                     4.3.2 Key customers
                     4.3.3 Key company market share analysis, 2018
                 4.4 Public Companies
                     4.4.1 Regional network map
                     4.4.2 Company market position analysis
                     4.4.3 Company market share, by region
                 4.5 Private Companies
                     4.5.1 List of key emerging companies
                     4.5.2 Company market position analysis
                 4.6 Supplier ranking
Chapter 5 Organ Transplant Immunosuppressant Drugs Market: Drug Class Estimates and Trend Analysis
                 5.1 Definitions & Scope
                 5.2 Market Share Analysis, 2018 & 2026
                 5.3 Segment Dashboard
                 5.4 Global Organ Transplant Immunosuppressant Drugs Market, by Drug Class, 2015 to 2026
                 5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
                     5.5.1 Calcineurin Inhibitors MArket
                         5.5.1.1 Calcineurin Inhibitors Market, 2015 to 2026 (USD Million)
                     5.5.2 Antiproliferative Agents MArket
                         5.5.2.1 Antiproliferative Agents Market, 2015 to 2026 (USD Million)
                     5.5.3 mTOR Inhibitor MArket
                         5.5.3.1 mTOR Inhibitor Market, 2015 to 2026 (USD Million)
                     5.5.4 Steroids MArket
                         5.5.4.1 Steroids Market, 2015 to 2026 (USD Million)
                     5.5.5 Antibodies MArket
                         5.5.5.1 Antibodies Market, 2015 to 2026 (USD Million)
Chapter 6 Organ Transplant Immunosuppressant Drugs Market: Transplant Type Estimates and Trend Analysis
                 6.1 Definitions & Scope
                 6.2 Market Share Analysis, 2018 & 2026
                 6.3 Segment Dashboard
                 6.4 Global Organ Transplant Immunosuppressant Drugs Market, by Transplant Type, 2015 to 2026
                 6.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
                     6.5.1 Kidney Market
                         6.5.1.1 Kidney Market, 2015 to 2026 (USD Million)
                     6.5.2 Liver Market
                         6.5.2.1 Liver Market, 2015 to 2026 (USD Million)
                     6.5.3 Heart Market
                         6.5.3.1 Heart Market, 2015 to 2026 (USD Million)
                     6.5.4 Lung Market
                         6.5.4.1 Lung Market, 2015 to 2026 (USD Million)
                     6.5.5 Pancreas Market
                         6.5.5.1 Pancreas Market, 2015 to 2026 (USD Million)
                     6.5.6 Others Market
                         6.5.6.1 Others Market, 2015 to 2026 (USD Million)
Chapter 7 Organ Transplant Immunosuppressant Drugs Market: Distribution Channel Estimates and Trend Analysis
                 7.1 Definitions & Scope
                 7.2 Market Share Analysis, 2018 & 2026
                 7.3 Segment Dashboard
                 7.4 Global Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, 2015 to 2026
                 7.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
                     7.5.1 Hospital Pharmacies Market
                         7.5.1.1 Hospital Pharmacies market, 2015 to 2026 (USD Million)
                     7.5.2 Retail Pharmacies Market
                         7.5.2.1 Retail Pharmacies market, 2015 to 2026 (USD Million)
                     7.5.3 Online Pharmacies Market
                         7.5.3.1 Online Pharmacies market, 2015 to 2026 (USD Million)
Chapter 8 Organ Transplant Immunosuppressant Drugs Market: Regional Estimates & Trend Analysis
                 8.1 Regional Market Snapshot
                 8.2 Regional Market Share and Leading Players, 2018
                     8.2.1 North America
                     8.2.2 Europe
                     8.2.3 Latin America
                     8.2.4 Asia Pacific
                     8.2.5 Middle East & Africa
                 8.3 Market Share Analysis by Country, 2018
                     8.3.1 North America
                         8.3.1.1 U.S.
                         8.3.1.2 Canada
                     8.3.2 Europe
                         8.3.2.1 UK
                         8.3.2.2 Germany
                         8.3.2.3 Spain
                         8.3.2.4 France
                         8.3.2.5 Italy
                         8.3.2.6 Russia
                     8.3.3 Latin America
                         8.3.3.1 Brazil
                         8.3.3.2 Mexico
                         8.3.3.3 Argentina
                     8.3.4 Asia Pacific
                         8.3.4.1 Japan
                         8.3.4.2 China
                         8.3.4.3 India
                         8.3.4.4 South Korea
                         8.3.4.5 Singapore
                         8.3.4.6 Australia
                     8.3.5 Middle east & Africa
                         8.3.5.1 South Africa
                         8.3.5.2 Saudi Arabia
                         8.3.5.3 UAE
                 8.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
                     8.4.1 North America
                     8.4.2 Europe
                     8.4.3 Latin America
                     8.4.4 Asia Pacific
                     8.4.5 Middle East & Africa
                 8.5 Market Size & Forecasts, and Trend Analysis, 2018 to 2026
                     8.5.1 North America
                         8.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                         8.5.1.2 U.S.
                             8.5.1.2.1 U.S. Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.1.3 Canada
                             8.5.1.3.1 Canada Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                     8.5.2 Europe
                         8.5.2.1 Europe Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.2.2 Uk
                             8.5.2.2.1 Uk Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.2.3 Germany
                             8.5.2.3.1 Germany Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.2.4 Spain
                             8.5.2.4.1 Spain Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.2.5 France
                             8.5.2.5.1 France Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.2.6 Italy
                             8.5.2.6.1 Italy Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.2.7 Russia
                             8.5.2.7.1 Russia Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                     8.5.3 Latin America
                         8.5.3.1 Latin America Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.3.2 Brazil
                             8.5.3.2.1 Brazil Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.3.3 Mexico
                             8.5.3.3.1 Mexico Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.3.4 Argentina
                             8.5.3.4.1 Argentina Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                     8.5.4 Asia Pacific
                         8.5.4.1 Asia Pacific Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.4.2 Japan
                             8.5.4.2.1 Japan Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.4.3 China
                             8.5.4.3.1 China Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.4.4 India
                             8.5.4.4.1 India Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.4.5 South Korea
                             8.5.4.5.1 South Korea Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.4.6 Singapore
                             8.5.4.6.1 Singapore Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.4.7 Australia
                             8.5.4.7.1 Australia Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                     8.5.5 Middle East & Africa
                         8.5.5.1 Middle East & Africa Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.5.2 South Africa
                             8.5.5.2.1 South Africa Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.5.3 Saudi Arabia
                             8.5.5.3.1 Saudi Arabia Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
                         8.5.5.4 Uae
                             8.5.5.4.1 Uae Market Size & Forecasts And Trend Analysis, 2015 To 2026 (USD Million)
Chapter 9 Company Profile
                 9.1 Company Profiles
                     9.1.1 Astellas Pharma Inc.
                         9.1.1.1 Company overview
                         9.1.1.2 Financial Performance
                         9.1.1.3 Product benchmarking
                         9.1.1.4 Strategic initiatives
                     9.1.2 Novartis AG
                         9.1.2.1 Company overview
                         9.1.2.2 Financial Performance
                         9.1.2.3 Product benchmarking
                         9.1.2.4 Strategic initiatives
                     9.1.3 F. Hoffmann-La Roche Ltd.
                         9.1.3.1 Company overview
                         9.1.3.2 Financial Performance
                         9.1.3.3 Product benchmarking
                         9.1.3.4 Strategic initiatives
                     9.1.4 Sanofi
                         9.1.4.1 Company overview
                         9.1.4.2 Financial Performance
                         9.1.4.3 Product benchmarking
                         9.1.4.4 Strategic initiatives
                     9.1.5 Pfizer, Inc.
                         9.1.5.1 Company overview
                         9.1.5.2 Financial Performance
                         9.1.5.3 Product benchmarking
                         9.1.5.4 Strategic initiatives
                     9.1.6 Bristol-Myers Squibb Company
                         9.1.6.1 Company overview
                         9.1.6.2 Financial Performance
                         9.1.6.3 Product benchmarking
                         9.1.6.4 Strategic initiatives
                     9.1.7 GlaxoSmithKline plc
                         9.1.7.1 Company overview
                         9.1.7.2 Financial Performance
                         9.1.7.3 Product benchmarking
                         9.1.7.4 Strategic initiatives

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies'/technology disruptors/innovators
Table 3 Global organ transplant immunosuppressant drugs market, by region, 2015 - 2026 (USD Million)
Table 4 Global organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 5 Global organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 6 Global organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 7 North America organ transplant immunosuppressant drugs market, by countries, 2015 - 2026 (USD Million)
Table 8 North America organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 9 North America organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 10 North America organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 11 U.S. organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 12 U.S. organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 13 U.S. organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 14 Canada organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 15 Canada organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 16 Canada organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 17 Europe organ transplant immunosuppressant drugs market, by countries, 2015 - 2026 (USD Million)
Table 18 Europe organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 19 Europe organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 20 Europe organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 21 Germany organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 22 Germany organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 23 Germany organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 24 UK organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 25 UK organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 26 UK organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 27 France organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 28 France organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 29 France organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 30 Spain organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 31 Spain organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 32 Spain organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 33 Italy organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 34 Italy organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 35 Italy organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 36 Russia organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 37 Russia organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 38 Russia organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 39 Asia Pacific organ transplant immunosuppressant drugs market, by countries, 2015 - 2026 (USD Million)
Table 40 Asia Pacific organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 41 Asia Pacific organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 42 Asia Pacific organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 43 Japan organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 44 Japan organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 45 Japan organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 46 China organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 47 China organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 48 China organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 49 India organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 50 India organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 51 India organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 52 South Korea organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 53 South Korea organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 54 South Korea organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 55 Singapore organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 56 Singapore organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 57 Singapore organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 58 Australia organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 59 Australia organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 60 Australia organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 61 Latin America organ transplant immunosuppressant drugs market, by countries, 2015 - 2026 (USD Million)
Table 62 Latin America organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 63 Latin America organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 64 Latin America organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 65 Brazil organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 66 Brazil organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 67 Brazil organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 68 Mexico organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 69 Mexico organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 70 Mexico organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 71 Argentina organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 72 Argentina organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 73 Argentina organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 74 MEA organ transplant immunosuppressant drugs market, by countries, 2015 - 2026 (USD Million)
Table 75 MEA organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 76 MEA organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 77 MEA organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 78 South Africa organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 79 South Africa organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 80 South Africa organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 81 Saudi Arabia organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 82 Saudi Arabia organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 83 Saudi Arabia organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Table 84 UAE organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Table 85 UAE organ transplant immunosuppressant drugs market, by transplant type, 2015 - 2026 (USD Million)
Table 86 UAE organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Organ transplant immunosuppressant drugs market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Organ transplant immunosuppressant drugs market snapshot (2018)
Fig. 9 Competitive insights (2018)
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Organ transplant immunosuppressant drugs market driver impact
Fig. 14 Organ transplant immunosuppressant drugs market restraint impact
Fig. 15 Organ transplant immunosuppressant drugs industry challenges
Fig. 16 Porter's five forces analysis
Fig. 17 SWOT analysis, by factor (Political & legal, economic and technological)
Fig. 18 Strategic alliance analysis
Fig. 19 Recent developments & impact analysis, by key market participants
Fig. 20 Key company market share analysis, 2018
Fig. 21 Company market share/ranking, by region
Fig. 22 Company market position analysis
Fig. 23 Supplier ranking
Fig. 24 Organ transplant immunosuppressant drugs market share analysis, by drug class, 2018 & 2026 (%)
Fig. 25 Segment dashboard
Fig. 26 Global organ transplant immunosuppressant drugs market, by drug class, 2015 - 2026 (USD Million)
Fig. 27 Calcineurin inhibitors market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 28 Antiproliferative agents market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 29 mTOR inhibitors market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 30 Steroids market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 31 Antibodies market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 32 Organ transplant immunosuppressant drugs market share analysis, by transplant, 2018 & 2026 (%)
Fig. 33 Segment dashboard
Fig. 34 Global organ transplant immunosuppressant drugs market, by transplant, 2015 - 2026 (USD Million)
Fig. 35 Kidney transplants market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 36 Liver transplants market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 37 Heart transplants market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 38 Lung transplants market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 39 Pancreas transplants market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 40 Other transplants market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 41 Organ transplant immunosuppressant drugs market share analysis, by transplant, 2018 & 2026 (%)
Fig. 42 Segment dashboard
Fig. 43 Global organ transplant immunosuppressant drugs market, by distribution channel, 2015 - 2026 (USD Million)
Fig. 44 Hospital pharmacies market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 45 Retail pharmacies market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 46 Online pharmacies market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 47 Organ transplant immunosuppressant drugs market: Snapshot, 2018
Fig. 48 North America organ transplant immunosuppressant drugs market share and leading players, 2018
Fig. 49 Europe organ transplant immunosuppressant drugs market share and leading players, 2018
Fig. 50 Asia Pacific organ transplant immunosuppressant drugs market share and leading players, 2018
Fig. 51 Latin America organ transplant immunosuppressant drugs market share and leading players, 2018
Fig. 52 Middle East and Africa organ transplant immunosuppressant drugs market share and leading players, 2018
Fig. 53 North America organ transplant immunosuppressant drugs market share analysis by country, 2018
Fig. 54 Europe organ transplant immunosuppressant drugs market share analysis by country, 2018
Fig. 55 Asia Pacific organ transplant immunosuppressant drugs market share analysis by country, 2018
Fig. 56 Latin America organ transplant immunosuppressant drugs market share analysis by country, 2018
Fig. 57 Middle East and Africa organ transplant immunosuppressant drugs market share analysis by country, 2018
Fig. 58 North America SWOT analysis, by factor (political & legal, economic and technological)
Fig. 59 Europe SWOT analysis, by factor (political & legal, economic and technological)
Fig. 60 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
Fig. 61 Latin America SWOT analysis, by factor (political & legal, economic and technological)
Fig. 62 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
Fig. 63 North America organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 64 U.S. organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 65 Canada organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 66 Europe organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 67 UK organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 68 Germany organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 69 Spain organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 70 France organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 71 Italy organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 72 Russia organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 73 Asia Pacific organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 74 China organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 75 Japan organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 76 India organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 77 South Korea organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 78 Singapore organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 79 Latin America organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 80 Brazil organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 81 Mexico organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 82 Argentina organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 83 Middle East and Africa organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 84 South Africa organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 85 Saudi Arabia organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 86 UAE organ transplant immunosuppressant drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)